权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Genetic analysis of Primary Pulmonary Hypertension and possible involvement of Tbx genes via BMP signaling in the pathogenesis of PPH.

原发性肺动脉高压的遗传分析以及 Tbx 基因可能通过 BMP 信号传导参与 PPH 的发病机制。

基本信息

批准号：
16590265
负责人：
MORISAKI Hiroko
金额：
$ 1.92万
依托单位：
National Cardiovascular Center Research Institute
依托单位国家：
日本
项目类别：
Grant-in-Aid for Scientific Research (C)
财政年份：
2004
资助国家：
日本
起止时间：
2004 至 2005
项目状态：
已结题

来源：
https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-16590265/
关键词：
Primary Plumonary Hypertension Genetic Analysis BMPR2 ALK1 BMP Tbx2 Has2 原発性高血圧症

项目摘要

1. Primary pulmonary hypertension (PPH) is a potentially lethal disorder, in which heterozygous mutations within the bone morphogenetic protein type II receptor gene (BMPR2) have been identified. We performed the molecular study of BMPR2 gene as well as ALK1 gene in 71 Japanese patients with PPH including 7 familial PPH cases (6 families), who visited the Division of Cardiology in NCVC. We also performed the molecular study in 64 cases with secondary pulmonary hypertension (SPH). We identified mutations of BMPR2 gene in 27 cases (38%) of patients with PPH, including all familial PPH cases, while only one patient with SPH was found to have BMPR2 mutation. Furthermore, three cases (4%) of patients with PPH and one with SPH were found to have ALK1 mutations. Those mutations are predicted to result in a premature termination codon or substitution of highly conserved amino acid residues. We also analyzed the age of onset among sporadic PPH patients according to genetic background. The mean age at onset was significantly younger in those with mutations than those without mutations, suggesting a considerable genetic predisposition underlying the pathogenesis of PPH. Furthermore, genetic analysis of family members of familial PPH revealed a very low penetrance (1 in 8 affected was eventually developed PPH) Based on these results, there is considerable genetic heterogeneity of PPH, and further functional study will be needed to identify pathophysiological mechanism of pulmonary hypertension.2. We demonstrate that Tbx2 is important for cardiac morphogenesis by using inducible mTbx2-misexpression mice. The mTbx2-overexpressing mice showed the changes of chamber-specific gene expression of Nppa, Smpx, Gja5,Myh7 and Myl7 at E9.5 and E9.75. In addition, we found the expression of Hyaluronan Synthase 2 (Has2) was upregulated in the ventricles during cardiogenesis. Also, we observed excessive HA secretion in the ventricular myocytes of mTbx2-misexpressing embryos.

1.原发性肺动脉高压（PPH）是一种潜在的致命疾病，其中骨形态发生蛋白II型受体基因（BMPR 2）内的杂合突变已被确定。我们对71例日本PPH患者进行了BMPR 2基因和ALK 1基因的分子研究，其中包括7例家族性PPH病例（6个家族），他们访问了NCVC的心脏科。我们还对64例继发性肺动脉高压（SPH）进行了分子生物学研究。我们在27例（38%）PPH患者中发现了BMPR 2基因突变，包括所有家族性PPH病例，而仅在1例SPH患者中发现了BMPR 2基因突变。此外，3例（4%）PPH患者和1例SPH患者被发现有ALK 1突变。预测这些突变会导致提前终止密码子或高度保守氨基酸残基的取代。我们还根据遗传背景分析了散发性PPH患者的发病年龄。突变患者的平均发病年龄明显小于无突变者，提示PPH的发病机制存在相当大的遗传易感性。此外，对家族性PPH家系成员的遗传分析显示，PPH的发病率很低（1/8的患者最终发展为PPH），因此，PPH存在相当大的遗传异质性，需要进一步的功能研究来明确肺动脉高压的病理生理机制.我们证明，Tbx 2是重要的心脏形态发生，通过使用诱导mTbx 2的错误表达小鼠。在E9.5和E9.75，mTbx 2过表达小鼠显示Nppa、Smpx、Gja 5、Myh 7和Myl 7的室特异性基因表达的变化。此外，我们发现在心脏发生过程中，心肌细胞中的Hybryonan合成酶2（Has 2）表达上调。此外，我们观察到过量的HA分泌的mTbx 2错误表达胚胎的心室肌细胞。